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Abstract
Establishing effective cage-side pain assessment methods is essential if post-surgical pain is to be controlled effectively in
laboratory animals. Changes to overall activity levels are the most common methods of assessment, but may not be the
most appropriate for establishing the analgesic properties of drugs, especially in mice, due their high activity levels. Use of
drugs that can affect activity (e.g. opioids) is also a problem. The relative merits of both manual and automated behaviour
data collection methods was determined in two inbred mouse strains undergoing vasectomy following treatment with one
of 2 buprenorphine dose rates. Body weights and the effects of surgery and buprenorphine on faecal corticosterone were
also measured. Surgery caused abnormal behaviour and reduced activity levels, but high dose buprenorphine caused
such large-scale increases in activity in controls that we could not establish analgesic effects in surgery groups. Only pain-
specific behaviour scoring using the manual approach was effective in showing 0.05 mg/kg buprenorphine alleviated post-
vasectomy pain. The C57 mice also responded better to buprenorphine than C3H mice, indicating they were either less
painful, or more responsive to its analgesic effects. C3H mice were more susceptible to the confounding effects of
buprenorphine irrespective of whether data were collected manually or via the automated approach. Faecal corticosterone
levels, although variable, were higher in untreated surgery mice than in control groups, also indicating the presence of pain
or distress. Pain-specific scoring was superior to activity monitoring for assessing the analgesic properties of
buprenorphine in vasectomised mice. Buprenorphine (0.01 mg/kg), in these strains of male mice, for this procedure,
provided inadequate analgesia and although 0.05 mg/kg was more effective, not completely so. The findings support the
recommendation that analgesic dose rates should be adjusted in relation to the potential severity of the surgical procedure,
the mouse strain, and the individual animals’ response.
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Introduction
Providing an effective dose of an analgesic to prevent pain in
laboratory mice first requires the development of appropriate
methods to identify its presence and evaluate its intensity. Efforts
to establish such methods have described use of generalised
behaviour changes [1–3], clinical assessments [4], measurements
of physiological changes such as faecal or plasma corticosterone
levels [2,3,5,6], or assessed heart rate and body temperature [7].
However, these have either not fully validated the parameters used
to assess pain, or require specialist recording equipment or
invasive methodologies (e.g. implanted telemetry devices, blood
sampling). The limited success so far achieved in studies using
behaviour is also due to the excessive time needed for assessments,
especially if large numbers of animals are involved. Due to their
highly active nature we have found this approach to be especially
challenging in mice, and this is probably why more comprehensive
dose recommendations for the large number of different rodent
surgical models are currently not available. Efforts to address this
have used automated behaviour analyses to increase the speed of
data collection [1,8–10]. However, this comes at the cost of
needing some specialised equipment and loss of specificity
regarding the individual behaviours that are included in the
ethogram. Others have used methods such as nest-building and
burrowing behaviour [11], both of which can be compromised by
pain, or more novel parameters such as changes in facial
expressions [12–14]. However, it remains to be established if
any of these methods are superior to activity scoring in providing a
means of identifying pain and the effects of analgesics in mice.
Another option is to use a ‘pain-specific’ approach whereby
subtle abnormal events are scored rather than generalised activity,
and we have previously demonstrated this to be highly effective in
rats [15–17]. This simplifies the scoring process and requires
minimal training [18] and so provides a practicable ‘cage-side’
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method of assessing pain in either singly or group housed animals.
Although we have used the pain-specific approach in vasectomised
mice given different doses of meloxicam [2] or paracetamol [10],
or these drugs combined [9], it was not more effective than activity
monitoring. It was possible to differentiate between normal and
surgery groups using pain-specific scoring, but not between groups
given different dose rates of analgesics. This is a critical step in
validating any proposed method of pain assessment intended for
use in mice, or in fact any other species. The lack of positive effects
of drug treatment reported by our group across a relatively wide
range of doses of meloxicam (between 5 and 20 mg/kg [2]) has
been replicated with other NSAIDs [1,14]. This leaves the
possibility that mice either require considerably higher dose rates
of NSAIDs, or that they may be comparatively unresponsive to
this class of drug. Although opioids offer an alternative and are
probably a more potent option than NSAIDs, they tend to be
avoided in behavioural studies due to their non-specific (con-
founding) effects upon normal behaviour. Drugs such as bupre-
norphine are known to increase activity levels [19–21], however,
more subtle behaviours that could be caused by pain might be less
affected.
As we have done previously, this study utilised a multi-faceted
approach using both manual and automated behaviour analyses,
and measured the endocrine stress response to surgery (by non-
invasive faecal corticosterone assay). We investigated the effects of
buprenorphine in 2 mouse strains (C57BL/6Crl and C3H/
HeNCrl) in an attempt to distinguish between its analgesic and
non-specific effects. We wished to establish if pain-specific
behavioural scoring under these circumstances provided a
practically useful means of evaluating the post-surgical welfare of
mice. The results showed buprenorphine can effectively relieve
pain in mice at a dose rate similar to that currently used in other
species, but this relies on applying an appropriate method of
behaviour scoring. Pain-specific scoring was more successful than
activity monitoring due to fewer confounding effects on behaviours
thought to be specifically linked to pain.
Materials and Methods
Ethics Statement
Mice underwent vasectomy as part of an on-going transgenic
mouse breeding program. No mice were used solely for the
purpose of assessing pain. All procedures were approved by the
UK Home Office (Project Licence PPL 60/3793) and by the
Newcastle University Animal Ethics Committee. The work also
complied with the guidelines of the Committee for Research and
Ethical Issues of the International Association for the Study of Pain
(IASP).
Animal Husbandry and Study Design
Inbred male mice (C57BL/6JCrl, n = 24 and C3H/HeNCrl,
n = 24) aged 10 weeks on arrival were obtained from a commercial
supplier (Charles River, Margate, UK). They were housed singly
upon arrival (Type MB2 cages, Techniplast UK Ltd, Northants.,
UK) for 2 weeks to acclimatise prior to the study. Sawdust was
provided as bedding (Gold Chip, BS and S Ltd., Edinburgh, UK).
Room temperature was maintained at 2461uC with 15–20 air
changes per hour. A 12 hour light-dark light cycle was used, with
lights going off at 19:00 h. Food pellets (R and M No. 1, SDS Ltd,
Essex, UK) and water were provided ad-libitum. Animals were
weighed daily for 1 week prior to surgery, on the day of surgery,
and on the day following surgery. Mice were randomly allocated
into six groups of eight (four of each strain per group). Three
groups underwent vasectomy (‘V’) via abdominal approach
surgery. Once anaesthetised, these were given a subcutaneous
injection of either saline (group VSa), or one of two doses of
buprenorphine (‘Bup’ 0.01 or 0.05 mg/kg; low dose group VBupL
and high dose group VBupH, respectively). Three sham groups;
one receiving saline, one low dose buprenorphine and one high
dose buprenorphine (groups ASa, ABupL and ABupH, respec-
tively) did not undergo surgery but underwent all of the same
preparations as the mice that underwent surgery, including
anaesthesia (indicated by ‘A’ in the treatment acronym). A
randomised block design ensured treatment groups were rando-
mised with respect to surgery day and the time of surgery.
Experimental Procedure
Mice were moved to the operating theatre before surgery began,
and injections were given subcutaneously in this room following
induction of anaesthesia with 5% isoflurane in 5 L/min oxygen.
The fur on the lower abdomen was shaved and the skin sprayed
with chlorhexidine (Hydrex Derma Spray, Adams Healthcare,
Leeds, UK). Surgery began at 08:00 hours, with the same
treatment-blinded surgeon operating on all mice. Anaesthesia
was maintained with 2–2.5% isoflurane in 1 L/min oxygen after
mice were individually placed on bedding (‘VetBed’, Kennel
Needs and Feeds, Morpeth, UK) on a heating blanket (Harvard
Apparatus, Edenbridge, Kent, UK) to maintain body temperature.
Surgery began with a 1.5 cm transverse incision through the skin
and abdominal muscles. The vas deferens was identified for both
testes and a portion (approximately 0.5 cm in length) of each vas
deferens was removed using cautery. The muscle and skin were
closed separately with 5/0 polyglactin 910 (‘Vicryl’, Ethicon Ltd,
Edinburgh, UK). Tissue glue (‘Nexaband’, Abbot Laboratories,
Queenborough, Kent, UK) was also applied to ensure closure of
the skin incision. In sham treated mice the surgical site was shaved
and chlorhexidine applied, and anaesthesia was maintained for a
period equivalent to that needed to complete surgery in the other
vasectomised groups (,15 minutes). Following the completion of
surgery or the sham procedure, animals were transferred to an
incubator maintained at 2863uC where they were closely
monitored for approximately 1 hour. Following this recovery
period they were transferred to a quiet adjacent room for filming
of post-operative behaviour.
Filming and Behaviour Data Collection
The data intended for manual analysis were collected by filming
each mouse for 6 minutes in a clear polycarbonate cage (Type
1144B, Tecniplast UK Ltd, Northants., UK) against a blue
background, using a digital video camera (Sony DSR-PD1P,
Japan) and ‘MiniDV’ tapes. A camera operator remained in the
room and used a tripod to closely track movements so that subtle
activities would be observable later. The mice were filmed again to
obtain data for analysis with the automated analysis system
HomeCageScan (HCS; Clever Systems Inc., USA). For this they
were placed into an identical adjacent cage and filmed for a
further 20 minutes, but with the camera fixed to the tripod and set
at 30 cm from the cage front. The operator left the room whilst
this footage was obtained. Filming cages contained sawdust
bedding (approximately 3 cm deep) but no food or water. These
were not necessary as experience showed such short behaviour
assessments virtually exclusively involve exploratory behaviour
irrespective of whether consumables are provided. A separate
advantage of this was that it prevented the food hopper or water
bottle obscuring the subject. The fixed camera position was
essential to successful use of HCS in providing an unchanging
background and preventing extraneous reflections (as occurs with
a person present). Cages were wiped clean with 70% ethanol,
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allow to dry, and bedding was renewed before filming mice from
different home-cages. At the end of filming mice were returned to
their home-cages and kept in a warm room (2461uC) for 24 hours
to further aid recovery. We did not collect any baseline (pre-
surgery) behaviour footage as the main focus was on evaluating
treatment differences, not the effect of repeated exposure to the
filming cages. Collecting and analysing these data would also have
been unduly time consuming.
Behaviour Data Analysis
The initial (6 minute) behaviour recordings were analysed by
one treatment-blinded observer using ‘The Observer Video Pro’
software (Version 5.0, Noldus Information Technology, Wagenin-
gen, NL). The frequency, and where appropriate the duration, was
calculated for each behaviour. Behaviours in the manual analysis
were selected from a previously established ethogram [2] with the
addition of one subsequently recognised and potentially relevant
act; ‘lie flat’.
The remainder of the behaviour data (20 minute segments)
were processed for automated analysis with HCS. Tapes were first
digitised in MPEG1 format and then transferred to a computer
running HCS software. The HCS system can be used either
‘online’ or ‘offline’ depending on the software version used. It
computes the occurrence of up to 38 pre-programmed mouse
behaviours. As with other versions, our ‘offline’ version (HPT3.0)
allowed data to be analysed at twice normal rate, hence results
were still obtained relatively rapidly.
Faecal Corticosterone Assay
Faeces were collected from individual mice 9 hours after
surgery. This was in line with previous observations that this
constituted the time of peak corticosterone excretion following
vasectomy in the strains of mice being investigated [2]. Baseline
samples were taken on the day prior to surgery, exactly 24 hours
before post-operative sampling. Baseline samples were collected in
the holding room, and post-operative samples were collected in a
room adjacent to the post-surgery recovery room. Faecal samples
were stored at 280uC prior to processing. Corticosterone was
extracted from the faeces using methanol. Briefly; 1 ml of 90%
methanol was added to each sample. These were then homoge-
nised using a mechanical homogeniser for 20–30 seconds and
subsequently vortexed at 22uC and 1400 rpm for 30 minutes. The
mixture was then centrifuged for a further 10 minutes at 25006g.
The supernatant was removed and dried in a Speedvac for 2–
4 hours at 45uC. The dried samples were stored at 280uC
overnight; re-suspended the following morning in 1 ml Dulbecco’s
Phosphate Buffered Saline, and vortexed for 1 minute at 22uC.
Hormone levels were determined using the IDS OCTEIA
Corticosterone HS Enzyme immunoassay kit (Immunodiagnostic
Systems Ltd., UK) according to the manufacturer’s guidelines.
Statistical Analysis
All statistical analyses were conducted using SPSS (SPSS,
Chicago, USA). The pre-operative body weights from the morning
of surgery (baseline values) were compared between groups by
univariate GLM with ‘Strain’, ‘Surgery’ and treatment ‘Group’ as
fixed factors. Calculations of the mean percentage change in
weight from baseline to 24 hours following surgery were then
compared with the same between-group factors. Post-hoc tests (with
Bonferroni probability correction) were used to highlight individual
group differences.
The baseline and post-operative corticosterone data were
analysed similarly. However, these data required log transforma-
tion to achieve normality. We determined the log change in
corticosterone values from baseline to the 9 h peak value
(log10(Peak/Baseline)) and compared this using the factors ‘Strain’
and ‘Surgery’, and then evaluated individual group differences as
before (Bonferroni).
The behaviour data obtained manually underwent initial
inspection using canonical discriminant analysis (DA). This was
to determine the extent of behavioural differences and the
individual activities contributing to any significant group separa-
tion. This technique effectively reduces large datasets by creating
fewer new variables termed canonical discriminant ‘Functions’.
The number of new discriminant Functions equals the number of
groups minus 1. Individual behaviours are tested for the strength
of their correlation with each newly created DA Function, so
allowing the identification of those principally responsible for
group differences. This, therefore, provided a convenient means of
identifying activities as either individually important or more
appropriate for computing composite (summary) scores. Analysis
of the composite scores and other behavioural outcomes of DA
was undertaken using a General Linear Model (GLM), again with
‘Surgery’, treatment ‘Group’ and ‘Strain’ as between-subjects
factors. Post-hoc tests (Bonferroni) were again also used to identify
individual differences according to treatment type and strain.
The data collected with HCS underwent a similar analysis
methodology, although the individual activities used differed from
those in the manual analysis. This was an unavoidable
consequence of the two data collection methods. HCS is ‘hard-
wired’ to the various elements of behaviour that the system scores,
whereas in manual analysis the user can include whichever
behavioural elements they so wish.
Finally, Pearson’s correlation was used to determine if/how the
various individual or composite behaviour scores determined from
the manual and automated scoring methods correlated with peak
corticosterone values. All results in the text and Table 1 are means
61 Standard error (SEM). Unless stated otherwise all figures show
mean value +1SEM. Corticosterone units are ng/g faeces. Alpha
level for all analyses was 0.05.
Results
Surgery and Anaesthesia
The combined mean time from induction to completing surgery
was 1562 minutes and there were no unexpected complications
or mortalities.
Behaviour – Manual Analysis
Preliminary DA determined activities differing most in response
to surgery. Activities were selected that positively or negatively
correlated with the one significant Function produced by the
analysis, with a cut-off R2 value of $0.1 or #20.1 (Function 1;
p,0.002, Wilk’s L). Six behaviours that correlated positively with
Function 1 (increased in response to surgery) and 10 that reduced
(correlated negatively) were used to generate two subset (compos-
ite) scores (Subset 1= +ve correlates; Subset 2=2ve). These
underwent additional analyses to evaluate the responses of the
various groups to saline or drug treatment. Subset 1 was found to
mainly comprise activities previously used as specific indices of
post-surgical pain in rodents; wound licking, hind-leg stretching
(‘rear leg lift’), an exaggerated form of pressing of the abdomen
into the substrate while stretching (‘Press2’) and abdominal
writhing. These were averaged to produce the composite measure
‘Score 1’. The final activity included in Subset 1 was abnormal
walking, whereby mice showed either an unsteady or otherwise
unusual stride pattern. This was not included in the averaged
calculation of Score 1 as it occurred with excessive overall
Behavioural Pain Assessment in C57 and C3H Mice
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frequency compared to the other Score 1 behaviours. For a similar
reason, 2 activities that showed the strongest negative correlation
with Function 1 were also examined separately; Normal Walking
(‘Walk Normal’) and periods of cessation of behaviour (‘Stop’)
where mice were not moving but obviously not asleep. The other
behaviours that correlated negatively with Function 1 were also
those that would typically be classed as ‘normal’ and occurred at a
frequency considered similarly acceptable (less than two-fold
difference overall) to be used to create a second composite score;
‘Score 2’. This included high bipedal rearing, head and face
washing (‘Lick Head’), digging, normal posturing and head/flank
scratching. Activities were assessed for both their frequency and
duration when appropriate (e.g. walking, grooming and rearing).
However, with the exception of data on time spent inactive (Stop),
the analysis found the duration data were no more effective than
the frequency results for illustrating group and strain differences.
As frequency measures are also more practicable for routine
behaviour scoring the figures only show frequency results.
However, the mean (61SE) frequencies and, where appropriate
the duration of all activities included in subsets 1 and 2, and the
individual behaviour used to calculate composite Scores 1 and 2
are given in Table 1.
Scores 1 and 2 and the remaining subset 1 and 2 activities were
then re-entered into a second discriminant analysis to determine
how they separated the groups according to whether mice
underwent surgery or only anaesthesia, or received a pre-
procedure injection of saline or buprenorphine. With 6 groups,
5 canonical Functions were produced. Figure 1 is a scatterplot of
the individual discriminant scores assigned to individuals on
Functions 1 and 2 for mice in each treatment. Both Functions
were found to be significant in terms of group separation
(p,0.001, Wilk’s L). As Figure 1 indicates, Functions 1 and 2
respectively explained 85 and 14% of the total variance. The
group separation shows the major factor driving behavioural
change was surgery, where Score 2 and other normal behaviours
correlated negatively with Function 1 (Score 2, r =20.59; Walk
Normal, r =20.46; Stop, r =20.3), whereas Score 1 and
Abnormal walking (pain-related behaviour) correlated positively
(r = 0.6; 0.35, respectively) with this Function. Pain-specific
behaviours (composite Score 1) correlated most strongly positively
Table 1. The results of manual behaviour analysis showing the mean (6SEM) frequency (counts) or duration (seconds) of
behaviours selected using Discriminant Analysis to compute Composite behaviour scores.
Treatment ASa ABupL ABupH VSa VBupL VBupH
Strain C57 C3H C57 C3H C57 C3H C57 C3H C57 C3H C57 C3H
Writhe 060.0 0.860.5 060.0 060.0 060.0 160.4 3.360.85 3.361.3 2.560.65 4.361.9 0.860.5 3.562.0
Press2 060.0 0.560.3 0.360.25 0.360.25 060.0 0.360.25 0.560.3 160.0 0.560.3 2.360.25 060.0 2.861.8
Rear Leg Lift 060.0 0.560.3 0.560.5 0.560.3 0.560.5 060.0 1.360.25 4.362.0 361.2 3.360.75 0.360.25 0.860.75
Lick Wound 2.861.2 0.360.25 0.560.5 1.360.5 160.7 060.0 1762.3 7.861 19.564.1 461.3 2.560.25 0.560.3
LW Duration 4.561.6 4.764.7 0.960.85 2.661.65 1.461.1 060.0 126.767 44.4617 103.2630 13.768.7 8.668.5 1.761.1
Scratch Wound 060.0 0.560.5 060.0 0.360.25 060.0 060.0 0.360.25 6.562.7 0.360.25 762.3 060.0 262.0
SW Duration 060.0 0.660.65 060.0 0.160.1 060.0 060.0 0.560.5 1062 0.460.4 11.264 060.0 0.660.55
Abnor Walk(1) 160.4 17610.5 1.560.3 4.862.7 20.5617 31.869.5 3266 39.866.5 47.562.2 51.565.6 46.365 51.3611.5
AW Duration 2.661.35 24.1612 3.460.95 9.865.5 67.5655 73.9622.5 91.6618 97.6619 143.4619 139.4627 280.9611 160.7645
High Rear 21.567.5 3163.8 23.562.6 2361.2 3.561.8 160.7 3.361.8 8.862.1 0.860.25 0.860.5 0.560.5 261.2
HR Duration 35.6612 49.268 32.965 35.264.1 3.862.3 1.160.8 3.961.9 1162.9 1.160.4 0.960.55 0.460.45 1.961.1
Lick Head 12.560.5 9.362.5 861.2 560.7 862.4 7.861.6 6.361.6 1.860.5 662 1.360.25 360.7 2.560.3
LH Duration 18.464.5 15.463.5 9.561.3 10.261.1 12.362.25 25.567 10.462 4.360.65 8.462 6.762.3 5.36.85 8.861.1
Scratch Head 160.4 2.360.85 1.360.5 060.0 0.560.5 060.0 0.860.5 060.0 0.36.25 060.0 0.360.25 060.0
SH Duration 0.660.25 1.160.4 0.960.3 060.0 0.460.35 060.0 0.660.45 060.0 0.460.45 060.0 0.560.45 060.0
Scratch ‘Other’ 0.86.5 160.0 0.860.5 0.360.25 0.360.25 060.0 0.360.25 0.360.25 0.360.25 060.0 060.0 060.0
SO Duration 0.560.3 0.860.15 0.760.4 0.360.25 0.260.16 060.0 0.360.35 0.360.35 0.360.35 060.0 060.0 060.0
Dig 33.868 16.563.0 30.3610 26.369.5 27.8615.5 1.861.2 2.561.8 9.566.4 0.360.25 0.360.25 0.560.5 060.0
DIG Duration 31.567.5 14.263.8 24.6610 23.469 41.9625.5 1.361 2.261.4 8.965.9 0.160.5 0.360.25 0.260.2 060.0
Normal Posture 21.868.5 9.565.5 1667 31.3611 3.861.9 5.362.3 0.560.3 10.364.6 0.360.25 3.560.72 160.4 4.862.25
NP Duration 195672.5 43625 196675 171652 249662 187.666.5 7.764.9 77634 4.964.9 234680 82.3665 251661.5
Walk Normal(2) 9067 72.868.5 98.363.6 99.366.2 61.3620.2 32.8613.1 12.864.7 28.3612 1.860.65 9.568.5 0.860.5 763.3
WN Duration 155613.5 105.368 199.3613 145.867 162657 97.9647.6 2469.3 50619 5.262.7 20.5616.2 6.260.55 13.468
Stop(2) 92.567.5 98.563.3 9466 99.862.8 73.367.1 73.368 65.564.3 73.5659 70.562.6 67.360.65 49.869 60613.5
Stop Duration 139616.5 19067 118.4614 167.968 72.162.8 154.6625 98613.9 143620 92615 167622.5 58.4610 170645
The scores were used to distinguish between the behaviour of groups of C57 and C3H mice. Mice underwent treatment indicated as Anaesthesia ‘A’ or Vasectomy ‘V’
surgery and were given a pre-procedure s/c injection of saline (Sa) or High ‘H’ or Low ‘L’ dose Buprenorphine ‘Bup’. Four mice of each strain underwent each treatment
type. Light shading indicates behaviours averaged to compute composite Score 1 (pain-specific measure); those shaded darker were used in Score 2 (Normal behaviour
elements). Values in italics are duration of behaviour. Unshaded values were additional subset 1(1) or 2(2) components used in the DA (Figure 1) but not included in
composite Scores 1 or 2.
doi:10.1371/journal.pone.0075948.t001
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with Function 2 (r = 0.74). Overall, these various relationships
between occurrence of normal and abnormal behaviour and how
these were affected by surgery and buprenorphine treatment
resulted in a ‘V’ shaped distribution of discriminant scores.
We hypothesised that Score 1 would increase in mice
undergoing surgery relative to the non-surgery groups and would
be lessened by pre-surgery buprenorphine, whereas the opposite
would occur with Score 2; i.e. be greater in control mice and those
given pre-surgery buprenorphine (if this effectively reduced pain).
As shown in Figure 2, Score 1 (pain-specific behaviour) was
found to differ significantly between treatment groups
(F(4,36) = 16.4, p,0.001), and surgery was the single most
significant factor resulting in increased evidence of pain
(F(1,46) = 56.3, p,0.001), but there were no overall strain
differences in response to surgery (p = 0.8). Post-hoc analyses using
these data found pain-related behaviour was highly significantly
(p,0.001) more frequent in both the untreated vasectomised mice
(VSa) and those given low dose buprenorphine (VBupL) than any
other group, but these groups did not differ significantly from each
other (hence no effect of low dose buprenorphine). The high dose
surgery group (VBupH) showed significantly less Score 1
behaviour (indicating less pain) than both other surgery groups
(P,0.001), to the extent that this pain-specific score 1 was
equivalent (not significantly different from) each of the control
groups. There were no significant differences between any of the
control groups. However, high dose pre-surgery buprenorphine
had a greater impact on C57 mice. These showed a greater
reduction in pain-related behaviour than the C3H mice, with
significantly reduced Score 1 frequency compared to either other
surgery group (VSa, p = 0.008; VBupL, p= 0.003). The response
of C3H mice was less pronounced, as comparisons with the
relevant other C3H surgery groups were not significantly different
(but only marginally so in the comparison with VSa; p = 0.051).
Figure 3 shows the frequency of abnormal walking (identified as
pain-associated by DA). The analysis showed an overall ‘Group’
effect (F(1,36) = 3, p = 0.028), indicating the various treatments
significantly affected this activity. Abnormal walking appeared to
be somewhat more frequent in C3H mice, but ‘Strain’ was not
significant. As Figure 3 illustrates, the surgery factor was also
significant (F(1,46) = 412, p,0.001) as abnormal walking was
increased in all surgery groups. Bonferroni analysis showed
significantly more frequent abnormal behaviour in the untreated
surgery group (VSa) than in either the untreated control group
(ASa; p= 0.031) or in controls given low dose buprenorphine
(ABupL; p= 0.004), but not compared to the high dose controls
(VBupH) where abnormal activity also increased (possibly
indicating non-specific (confounding) effects of buprenorphine on
this behaviour). This was not seen following low dose buprenor-
phine, where, like the other control groups, there was significantly
less abnormal walking behaviour than in any of the surgery groups
(p = 0.004, ,0.001, ,0.001; for comparisons of ABupL with
groups VSa, VBupL and VBupH, respectively). There were also
no significant differences found between any of the individual
surgery groups and no individual difference in the responses of the
two strains either to surgery or the control treatments. Although
high dose buprenorphine seemed to increase abnormal walking in
C3H controls, relatively large variation rendered this comparison
non-significant also.
Figure 1. Plot of canonical discriminant scores for individual mice of each strain in each treatment group according to pain-specific
behaviours scored 1 hour following anaesthesia or surgery (A or V; none versus red symbol borders). Mice were given saline (Sa; blue
filled squares) or low or high dose buprenorphine (BupL (0.01 mg/kg) or BupH (0.05 mg/kg); indicated by orange or brown filled circles respectively).
The significance of each Function in separating groups, and the % contribution to between-groups variance is given in brackets on each axis label.
Note the significant separation depending on whether groups underwent surgery (Factor 1; p,0.001), and the effect of pre-surgery buprenorphine
(VBupH; Function 2; p,0.001) resulting in the ‘V’ shaped convergence of individual scores; buprenorphine reduced abnormal behaviour to an extent
similar to that seen in controls (groups ASa, ABupL, ABupH). (n = 8 per group).
doi:10.1371/journal.pone.0075948.g001
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Figure 2. The mean frequency of the pain-specific composite behaviour measure ‘Score 1’ (+1SE) obtained via manual analysis.
Behaviours indicating pain were not present in control groups given Saline (ASa), or low or high dose buprenorphine (ABupL, ABupH) but were
significantly elevated in groups that underwent surgery following only Saline or 0.01 mg/kg buprenorphine (VSa, VBupL). The pain signs were
attenuated by 0.05 mg/kg buprenorphine in both strains, but more so in C57 mice (n = 8 per treatment; comprising 4 of each strain). Symbols
indicate results of Bonferroni comparisons: 1 C57 (VBupH) differs significantly from C57 mice in treatment groups VSa and VBupL (p = 0.008; p = 0.003,
respectively); * Group VBupH differs significantly from VSa and VBupL (p,0.001).
doi:10.1371/journal.pone.0075948.g002
Figure 3. The mean frequency of abnormal walking behaviour (+1SE) in C57 and C3H mice in each control and surgery group. High
dose buprenorphine significantly increased abnormal behaviour frequency in controls (group ABupH) making it impossible to determine any post-
surgical analgesic effects. (n = 8 per group; 4 of each strain). Symbols indicate individual group comparisons: * Group VSa cf. Asa, ABupL (p = 0.031,
0.004, respectively); 1 Group ABupL cf. VSa, VBupL, VBupH (p= 0.004, ,0.001, ,0.001, respectively).
doi:10.1371/journal.pone.0075948.g003
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Three summary measures of normal behaviour were tested;
composite Score 2, Walk Normal and Stop. The frequency of
Score 2 is shown in Figure 4. The relative occurrence of Score 2
in the various groups was virtually the reciprocal of the
abnormal walking frequency shown in Figure 3, but here
(Figure 4) occurring significantly more overall in the non-
surgery versus surgery groups (F(1,46) = 52, p,0.001). There
was also a significant overall treatment effect (F(4,36) = 8.4,
p,0.001), but again no overall strain difference. Unsurprisingly,
behaviour was relatively normal in the untreated controls (ASa),
and as seen with Score 1 and abnormal walking, the low dose of
buprenorphine again had little impact on controls (group
ABupL). The mice in the latter group also showed more normal
behaviour than any other group (p#0.001 for all post-hoc
comparisons) except group ASa. However, high dose bupre-
norphine significantly impacted by reducing the normal
behaviour of controls (ABupH) to the extent that this group
was not significantly different from any of the surgery groups
(p.0.08 for each Bonferroni adjusted comparison). This effect of
buprenorphine was especially apparent in C3H mice. Those in
the low dose control group (ABupH) showed significantly less
normal behaviour than both other C3H control groups (ASa,
p = 0.039; ABupL, p = 0.008). Notably, the high drug dose given
to control C3H mice caused as great a reduction in normal
behaviour as that caused by surgery alone, or either surgery
group given buprenorphine. By contrast, the depressing effect
on normal behaviour in C57 mice was relatively minor, and the
behaviour of the C57 mice in group ABupH was not
significantly different from that in the other C57 control groups
(ABupH C57 compared to ASa or ABupL; p$0.15 in each
case). Compared to Score 2, normal walking occurred with a
considerably greater magnitude overall, but strain effects and
the pattern of response according to treatment were so similar to
Score 2 that it was unnecessary to depict the results graphically.
They can be found in Table 1.
Surgery significantly reduced the overall frequency of inactivity
(‘Stop’) (F(1,46) = 28, p,0.001; Figure 5) so mice were overall
more active. There were no significant overall strain differences,
but ‘treatment’ was significant (F(5,42) = 12, p,0.001). Bonferroni
comparisons showed this arose because high dose buprenorphine
reduced the frequency of inactive periods in both the control and
surgery groups (ABupH and VBupH). These groups did not
significantly differ from each other, and the high dose control mice
were significantly more active (‘Stop’ further reduced) by
comparison with both of the remaining control groups (ABupH
vs. ASa, ABupL; p= 0.031, p = 0.017, respectively) who were
more frequently inactive than all other groups (p#0.031 for each
individual comparisons). There were no significant effects of
surgery or overall effect of treatment on time spent inactive (Stop
duration as opposed to frequency; Table 1). However, in line with
the frequency results, untreated control mice (ASa) spent more
time inactive than most other groups, including the low dose drug
controls (ABupH, p= 0.017), the untreated vasectomised mice
(VSa, p = 0.037) and the high dose surgery group (VBupH,
p= 0.019). These effects, however, were mainly due to the greater
magnitude of changes in C57 mice. Overall these mice spent
considerably less time inactive (‘Stopped’) than the C3H mice
(‘Strain’ factor significant; F(1,36) = 35, p,0.001), and the main
contributors to this overall difference were the C57 groups
ABupH, VSa, VBupL and VBupH who spent a comparatively
shorter time inactive.
Figure 4. The mean frequency of the Composite normal behaviour measure ‘Score 2’ (+1SE) obtained from manual behaviour
analysis. This was computed from the occurrences of bipedal high rearing, head and face washing (‘Lick Head’), digging, normal posturing, head
scratching or of other body regions (e.g. flank). Note the significant reduction in normal behaviour caused by buprenorphine in both strains (ABupH),
which was significant in C3H mice in this group compared to both other control groups. (n = 8 per group; 4 of each strain). Symbols indicate
individual group and strain results whereby: * Group ABupL, Score 2 significantly greater frequency than all other groups except Asa (p#0.001); 1
C3H mice in group ABupH vs. C3H groups Asa, ABupL (p = 0.039, 0.008, respectively).
doi:10.1371/journal.pone.0075948.g004
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Behaviour – Automated Analysis (HCS)
The analysis registered 29 of the 38 behaviours the HCS system
can record. As in the manual analysis, these were entered into DA
with surgery as the between-subject’s grouping variable. This
produced one significant canonical Function (Function 1;
p = 0.002, Wilk’s L). Twelve variables (behaviours) that met the
R2 cut-off previously applied ($0.1/#20.1) all correlated
positively with this Function (i.e. reduced in response to surgery).
Grooming and stationery (Stop) periods were the only variables
that correlated negatively with Function 1 (increased following
surgery) but only grooming met the R2 cut-off so ‘Stop’ was
excluded. The positively correlated variables were grouped
according to whether they occurred with Low, Medium or High
frequency. This was because their respective averaged frequencies
(over all groups) closely approximated to 10, 50 or 100 within each
20 minute recording. The low frequency group included: ‘Jump-
ing’ and ‘Come Down’; medium frequency activities were ‘Rear
Up’, ‘Walk Left’ and ‘Walk Right’, and the high frequency group
included ‘ComeDown’ from and to ‘Partially Reared’ (2 behav-
iours), ‘Rear Up’ from and to ‘Partially Reared’, ‘Remain Low’,
‘Remain Partially Reared’, ‘Sniff’ and ‘Walk Slow’. The Low,
Medium and High summary measures were then calculated.
These composite scores and grooming were used in an additional
DA analysis to determine how group behaviour characteristics
differed according to treatment type. This produced two
significant Functions (Function 1, P,0.001; Function 2,
p = 0.018, Wilk’s L) that together explained 99.5% of the
between-groups variance (72.7 and 26.8%, respectively). Figure 6
shows a scatter plot of the Function 1 and 2 discriminant scores
assigned to individual mice in each treatment group. The Low and
High frequency activities were most strongly positively correlated
with Function 1 (R2= 0.96, 0.76, respectively), whereas the
Medium frequency activities correlated positively with Function
2 (R2= 0.7) and grooming was negatively correlated with Function
1 (R2=20.52). As Figure 6 illustrates, there was a comparatively
greater dispersion of discriminant scores relative to those obtained
in the manual analysis (Figure 1) with several mice in the surgery
groups overlapping with controls. The principal outliers were
those given high dose buprenorphine; 2 of which were assigned a
disproportionately higher score on Function 1, and 3 mice on
Function 2 compared to the other mice undergoing surgery. The
results were further summarised by calculating a geometric
average of the results across the 3 behaviour categories
(Gbehave = 10‘((Log10(Low+16Medium+16High+1)/3)21) to
provide a general activity score. This was then compared between
groups using ANOVA with the factors previously described.
Based on the distribution of discriminant scores (Figure 6) our
Ad-hoc prediction was that Gbehave would be reduced in surgery
relative to non-surgery groups, with less clear strain and individual
treatment effects. The mean frequency of Gbehave (with 95%
Confidence Interval) is shown in Figure 7. Surgery was the most
influential factor unpinning behavioural alterations, and Gbehave
was significantly reduced in all vasectomised mice compared to
controls (F(1,37) = 70.3, p,0.001). There were no overall strain
differences, but treatment (F(4,37) = 4.2, p = 0.007) and the
interaction term ‘Treatment x Strain’ were also significant
(F(4,37) = 6.5, p,0.001). This was due to different responses to
treatments, and the differential responses of C57 and C3H mice.
The C3H mice tended to be more active following either saline or
low dose buprenorphine, regardless of whether they underwent
surgery. Primarily, however, the significant interaction arose
because Gbehave was only reduced by high dose buprenorphine
in the C3H mice, whereas C57 mice in this group were relatively
unaffected. Overall, the untreated and low dose controls (ASa,
ABupL) were significantly more active than both the untreated
and low dose buprenorphine vasectomy groups (p,0.001 for
respective comparison with groups VSa and VBupL). The low
dose buprenorphine controls were also more active than the high
dose vasectomy group (ABupL vs. VBupH; p= 0.002). There were
no overall group differences within the individual surgery or
Figure 5. The mean frequency of inactive periods ‘Stop’ (+1SE) in each control and surgery group in data collected manually.
Buprenorphine resulted in a decrease in periods of inactivity both in the control and surgery groups given the high dose of drug. A similar decrease in
inactivity also occurred in the other two surgery groups (VSa and VLBup). (n = 8 per group; 4 of each strain). Asterisks indicate groups Asa, ABupL
were significantly more frequently ‘Stopped’ than all other groups (p#0.031 for all individual comparisons).
doi:10.1371/journal.pone.0075948.g005
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control groups, however, separate strain analyses showed high
dose buprenorphine significantly reduced activity in C3H controls
(ABupH) relative to the other C3H control groups given saline or
low dose buprenorphine (p= 0.01, p = 0.001; cf. ASa, ABupL,
respectively). This buprenorphine-driven reduction in activity was
similar to that seen in all C3H mice following surgery. High dose
buprenorphine had the opposite effect in vasectomised C57 mice
where activity was significantly increased relative to either of the
other pre-surgery treatments (VBupH vs. VSa and VBupL,
p= 0.012, p = 0.011, respectively), but was significantly less in
C57 mice compared to their respective control high dose group
(VBupH vs. ABupH, p= 0.014).
The effects on grooming behaviour are shown in Figure 8,
where HCS found changes in response to the various treatments
were almost the opposite of those on general activity (Gbehave).
Surgery caused a highly significant increase in grooming frequency
(F(1,37) = 18.1, p,0.001), and the overall effect of treatment
‘Group’ was also significant (F(4,37) = 3.1, p = 0.027). Here,
however, there was also a marked strain difference, as C57 mice
groomed more overall (F(1,37) = 12, p = 0.001). There was a slight
tendency for high dose buprenorphine to reduce grooming in C57
controls relative to the other saline or low dose control groups, but
the reverse was apparent in C3H mice. Overall, buprenorphine
had relatively little impact on grooming in either strain and no
significant effects were found in strain comparisons between the
various control groups. Surgery caused an increase in grooming
and there was little evidence of a positive effect of buprenorphine
when both strains were included in the analysis. However, the C57
mice not only groomed more overall, but the effect of high dose
buprenorphine before surgery was also more obvious in these
mice. Compared to the other surgery groups, the C57 mice in
group VBupH showed a proportionately greater reduction in post-
surgery grooming. There was little or no evidence of this in C3H
mice. A one-way post-hoc ANOVA found no significant difference
between the 3 pre-surgery treatments in C3H mice, but the C57
mice given high dose buprenorphine showed significantly less
grooming compared to their counterpart groups given either low
dose buprenorphine (p = 0.043) or saline (p = 0.043) before
surgery. Additional post-hoc analyses (irrespective of strain) showed
the saline and low dose buprenorphine control groups groomed
less than their respective post-surgery counterparts: ASa vs. VSa
(p = 0.001); ABupL vs. VBupL (p = 0.002), and all other compar-
isons between these groups were also significant (ASa vs. VBupL,
p= 0.002; ABupL vs. VSa, p = 0.001). However, the two high dose
buprenorphine groups did not significantly differ from each other
(ABupH vs. VBupH, p= ns).
Body Weight Changes
The body weight changes were similar between strains, both in
terms of initial group variation and also in response to surgery.
The data were therefore pooled. The pre-operative body weights
of the mice did not differ significantly between the various
treatment groups. The total average weight on the morning of
surgery was 26.561 g. Surgery resulted in a significantly greater
percentage weight loss over the 2 days relative to controls
(F(1,46) = 17.8, p,0.001). The non-surgery mice showed a very
Figure 6. Plot of canonical discriminant scores for individual mice in each group according to Low, Medium and High frequency
normal behaviour data from analysis with HCS (Automated). Groups are identified as in the Figure 1 legend; the axis labels show the
significance of each Function and its respective percentage contribution to between-group variation. Although activity changes showed significant
separation of the surgery and control groups (Function 1; P,0.001), compared with the results of pain scoring there was a lack of differentiation
according to whether mice were treated with saline or buprenorphine. Low frequency measures were: ‘Jumping’ and ‘Come Down’; Medium
frequency: ‘Rear Up’, ‘Walk Left’ and ‘Walk Right’; High frequency: ‘ComeDown from and to Partially Reared’ (2 behaviours), ‘RearUp from and to
Partially Reared, ‘Remain Low’, Remain Partially Reared’, ‘Sniff’ and ‘Walk Slow’. (n = 8 per group).
doi:10.1371/journal.pone.0075948.g006
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Figure 7. Geometric mean frequency of the composite normal activity measure (Gbehave) from HCS (automated) analysis (with 95%
confidence intervals). The text gives details of how this was computed from the Low, Medium and High activity scores. Results were similar to
those obtained manually; surgery reduced normal behaviour incidence and C3H mice were more susceptible to the confounding effects of high dose
buprenorphine; i.e. normal behaviour was significantly depressed in this strain (group ABupH). (n = 8 per group; 4 of each strain). Symbols indicate
results of individual group comparisons: * Groups Asa, ABupL vs. VSa, VBupL (p,0.001 for respective comparisons); ¥ Group ABupL vs. VBupH,
p = 0.002); 1 C3H mice in group ABupH cf. Asa, ABupL (p = 0.01, p = 0.001, respectively); ‘ C57 mice in group VBupH vs. C57 mice in groups VSa,
VBupL (p = 0.012, 0.011, respectively); $ C57 mice in group VBupH cf. C57 mice in group ABupL (p = 0.014).
doi:10.1371/journal.pone.0075948.g007
Figure 8. The mean frequency of grooming behaviour (+1SE) following automated behaviour analysis with HCS. Grooming increased
in response to surgery but C3H mice groomed less overall. The C57 mice showed a greater increase following surgery which was significantly reduced
by high dose buprenorphine. However, this effect was again confounded by a similar response in high dose C57 controls (n = 8 per group; 4 of each
strain). Symbols show the results of individual comparisons: * Group ASa cf. VSa (p = 0.001); ‘ ABupL cf. VBupL (p = 0.002); ¥ ASa cf. VBupL (p = 0.002);
$ ABupL cf. VSa (p = 0.001); 1 C57 mice in group VBupH cf. C57 mice in groups VBupL, VSa (p = 0.043, both comparisons).
doi:10.1371/journal.pone.0075948.g008
Behavioural Pain Assessment in C57 and C3H Mice
PLOS ONE | www.plosone.org 10 September 2013 | Volume 8 | Issue 9 | e75948
slight gain (1.362 g) and post-surgery losses were relatively modest
overall (23.762 g). The treatment factor was also found to be
significant due to the greater effect of surgery on weight change
(‘Group’ factor significant; F(5,42) = 3.4, p = 0.01), however, the
only individual (post-hoc) groups where weight loss significantly
differed was in the anaesthesia control mice given low dose
buprenorphine compared to the surgery group given the higher
drug dose (ABupL vs. VBupH; p= 0.04). Overall, therefore,
weight losses were not remarkable and so are not depicted
graphically.
Corticosterone Analysis
Two mice were excluded due to an inability to obtain valid
faecal samples. Data from one other mouse in group VSa were
also excluded based on a baseline corticosterone value of
.800 ng/g; up to tenfold more than any other value recorded.
The results are shown in Figure 9. The mean baseline
(untransformed) corticosterone values were not significantly
different between strains; 30.363.6 ng/g in C57 mice compared
to 31.562.5 ng/g in the C3H strain. Overall, the corticosterone
data were highly varied, as were the individual groups’ responses
to treatment. Corticosterone levels (transformed values; Figure 9)
increased in all mice in response to all treatments, but more so in
those that underwent surgery (F(1,43) = 7.4, p= 0.009). Although
surgery in C57 mice also elevated corticosterone, the changes were
especially variable in this strain and the overall significant
‘Surgery’ effect was primarily due to the increase in C3H mice
(F(1,21) = 7.7, p = 0.011). Bonferroni analysis was again used to
determine any individual group differences. The C57 mice showed
a non-significant tendency to respond positively to low dose
buprenorphine (VBupL), but levels were elevated both in this
strain and also C3H mice following high dose buprenorphine
(VBupH). Due to the highly varied nature of the corticosterone
results there were no other significant findings to report. We
assessed relationships between the various behavioural parameters
and the results of corticosterone sampling. However, we could not
find any significant relationships between the apparently enhanced
stress response caused by surgery and any of the manually or
automatically obtained behaviour results.
Discussion
We investigated the effects of surgery and two doses of
buprenorphine administered to C3H and C57 mice undergoing
vasectomy. We hoped to detect signs of pain and to demonstrate
positive (or otherwise) effects of buprenorphine on welfare. The
study utilised both manual and computerised behavioural analyses
and assessed faecal corticosterone levels. These methods were
combined in a concerted effort to establish a more refined and
practically useful approach to post-surgical pain assessment in
mice than has so far been achieved.
We found pain-specific behaviours occurred following vasecto-
my, and scoring these was a more practicable and effective means
of assessing pain and the analgesic effects of buprenorphine than
general activity monitoring. Using this method we found
buprenorphine given at 0.05 mg/kg (s/c) reduced pain, but was
more effective in C57 mice. The C3H strain showed more pain-
related behaviour overall, and were also more susceptible to the
confounding effects of buprenorphine on behaviour. We found this
to be the case irrespective of whether data were collected manually
or using the automated system.
The ethogram used for the manual behaviour analysis was
developed in an earlier study where we assessed the effects of
meloxicam [2]. In that study, as here, we could not find any
particular behaviour(s) whose occurrence effectively distinguished
between treatments. As a result, we created summary (composite)
scores to illustrate the main findings. The composite scores
presently used were derived from the results of discriminant
analysis (Figure 1) where we determined which behaviours were
distinct between the surgery and non-surgery groups, and which
differentially changed in response to the 2 test doses of
Figure 9. Corticosterone levels detected in the faeces of C57 and C3H mice 9 hours following treatment (+1SE). Surgery caused an
overall increase in corticosterone, but extensive variation rendered efforts to establish analgesic (stress reducing) effects of buprenorphine non-
significant. (n = 8 per group; comprising 4 mice of each strain).
doi:10.1371/journal.pone.0075948.g009
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buprenorphine. The inclusion of individual behaviours in each
composite score was based on 2 qualifying criteria. Firstly, they
required statistical relevance (in separating the control and surgery
mice), but also potential for practical application such that they
should be recognisable by even inexperienced staff. Score 1
included some activities previously identified as likely to be pain-
related in both mice and rats [2,15], and together with abnormal
walking (which was assessed separately) provided our main pain-
specific index. Score 2 was mainly comprised of normal activities
(see Table 1), and grooming was also included as a normal activity.
The figures provide greater clarity concerning the outcomes of
discriminant analysis and how the data were subsequently
interpreted. As shown in Figures 2 and 3, the pain-specific index
‘Score 1’ and abnormal walking respectively increased following
surgery, but unlike in our previous experiments, use of ‘pain-
specific’ scoring also allowed us to identify significant dose effects.
Whereas the lower dose of buprenorphine was not effective, the
high dose (0.05 mg/kg) significantly attenuated the relevant
behaviours (Figure 2). Furthermore, we were able to identify strain
differences. Pain-specific behaviours were more frequent in C3H
mice following high dose buprenorphine. Assuming these indicated
pain, the C3H strain were therefore more painful than C57 mice.
This conclusion is supported by our most recent findings wherein
C3H mice showed a more elevated morphine conditioned place
preference than C57 mice during development of bladder cancer
[unpublished results]. That study also included automated analyses
of behaviour and found that behaviour changes were also more
extensive in C3H compared to C57mice at the same stage of cancer
development. These differential effects of high versus low analgesic
dose rates detected by cage-side scoring, and the apparent greater
sensitivity of one mouse strain compared to another confirm and
strengthen our preliminary findings of similar differences using
generalised activity [1,2]. However, direct observation of pain-
related behaviours seems to provide a more reliable and practicable
means of detecting these differences in pain susceptibility. As such
this approach is more likely to be useful in evaluating other mouse
strains, other drugs, or other types of surgical procedure. The
differences in responses to analgesic treatment in the two strains of
mice could be due to a number of different factors. Different inbred
strains of mice have been shown to vary in their nociceptive
thresholds [22]. In the latter study C3H mice showed over double
the response level compared to C57 mice in an abdominal
constriction test. The ED50 of opioids such as morphine also vary
considerably in different inbred strains of mice [23]. It is therefore
likely that both genetic influences on nociceptive processing and
differences in analgesic pharmacokinetics may contribute to the
strain variation demonstrated by our study and others.
The results of manual activity scoring are shown in Figures 4
and 5 (Score 2 and inactivity; ‘Stop’ frequency) and those with the
automated approach Figures 6, 7 and 8 (DA results, the summary
activity measure Gbehave and grooming, respectively). The findings
obtained via automated data collection were generally more
difficult to interpret than those obtained by pain-specific scoring.
Figure 6 exemplifies this, and shows that the level of discrimination
achieved between the various treatments was poor following
discriminant analysis of data collected with HCS. This was mainly
because, as was anticipated, buprenorphine had a range of
confounding effects on general activity. For example, the high dose
so adversely affected walking behaviour in controls (increased
Abnormal Walking) t it impossible to assess any analgesic effects.
Similarly, although surgery reduced normal behaviour frequency
in the manual assessment (Score 2: rearing, digging, grooming,
etc.; Figure 4), high dose buprenorphine also produced this effect
in controls. These confounding effects of buprenorphine are
relatively well known [19–21] and were also more obvious in
C3H mice. The HCS results also showed that both surgery and
buprenorphine significantly reduced our summary measure of
normal behaviour (Gbehave) in controls, and the C3H mice were
again most affected (Figure 7; group ABupH). As before, this made
it impossible to establish the extent to which drug treatment per se
contributed to the post-operative findings in the drug treated
groups. Finally, all surgery groups and the controls given high dose
buprenorphine were more active overall (‘Stop’ frequency decreased;
Figure 5). The net consequence of this was that, by comparison with
pain-specific scoring, the activity measures were less useful as
markers of welfare. Such non-specific effects on behaviour may have
been less pronounced had we been using NSAIDs rather than
opioids. However, as previously mentioned, it seems likely that
comparatively high (potentially toxic) dose rates of NSAIDs may be
necessary to achieve effective pain relief in mice.
The buprenorphine dose rates were meant to be in the lower
range still likely to provide effective pain relief, but minimise
potential confounds. When given at 0.2 mg/kg (s/c) buprenorphine
not only causes loss of body weight [24,25], but also other unwanted
behavioural effects that prevent reliable pain scoring [24]. More
frequent dosing or use of a higher dose rate (2.4 mg/kg i/p) may not
only adversely affect food and water consumption, but can also
cause hyperthermia and hyperactivity [19]. In the present study all
mice that underwent surgery lost weight. Although we could not
detect any beneficial effect of buprenorphine in terms of preventing
this, we avoided the adverse effects associated with higher dose
rates. The choice of dose rate was also informed by a reported
efficacy of 50% (0.01 mg/kg) and 100% (0.05 mg/kg) in the mouse
abdominal constriction assay, and a 50% effect in hot-plate testing
[26]. The limitations of these types of nociceptive tests are well
known, and it can be hazardous to extrapolate from their outcomes
in estimating therapeutic dose rates. The current study was an
attempt to evaluate 2 relatively commonly used doses. Our data
suggest the lower dose (0.01 mg/kg), in these strains of male mice,
and for this surgical procedure, provided inadequate analgesia.
Although the higher dose (0.05 mg/kg) had positive effects, it was
probably also not completely effective. This is supported by the
results of a recent study on the effects of vasectomy using the mouse
grimace scale [13]. This showed a significant improvement with
0.05 mg/kg, with a possibly greater effect of 0.1 mg/kg (although
this analysis was not reported by the authors). Unfortunately the
present study was completed prior to development of the mouse
grimace scale, and the quality of video recording, together with the
method of filming meant our data were not suitable for retrospective
analysis using this approach.
There was a clear trend to towards higher faecal corticosterone
concentrations in untreated mice that underwent vasectomy.
However, due to considerable variation in all treatment groups
we were unable to detect any beneficial effects of either dose rate of
buprenorphine. Baseline corticosterone values were very similar to
those from a previous study [2], with samples taken at the same time
point in normal control animals. It was therefore unlikely that the
observed variable increase in corticosterone was a consequence of
the sampling method or analysis. As similar variation has previously
also been reported following surgery in both rats and mice [2,5,6], it
seems corticosterone may be more effective as a stress marker than
as a measure of post-procedural analgesic efficacy.
In previous studies of the effects of vasectomy in mice we
reported on how automating behaviour analyses can reduce the
time needed to conduct assessments without sacrificing relevance
[1,8]. However this work did not involve scoring pain-specific
indicators, largely because the HCS system cannot detect them.
Although originally marketed as a user-trainable system, the level
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of flexibility that would be needed to train the system to score these
behaviours has not yet been achieved. Nevertheless, HCS remains
a valuable tool to rapidly phenotype mice, such as in testing drugs
that are supposed to affect motivation or anxiety. Until it has
undergone further development it seems HCS has limited value in
studies specifically evaluating pain.
Prior to undertaking this study our only convincing evidence of
an effective treatment for vasectomy pain was reduced faecal
corticosterone in mice given 20 mg/kg meloxicam. A considerably
lower dose rate of meloxicam (1 mg/kg s/c) is effective in rats
using a similar pain-specific approach to scoring [16], and
buprenorphine at the commonly administered subcutaneous dose
rate of 0.05 mg/kg also substantially reduces pain-specific rat
behaviour [17]. As present results indicate buprenorphine given at
0.05 mg/kg was at least partially effective in mice, the apparent
disparity in analgesic needs between rats and mice may not be so
great when opioids are used.
Conclusions
These data support the use of behavioural scoring as a means of
assessing post-surgical pain in mice, but in particular, they indicate
that assessing pain-specific behaviours is a more effective approach
than general activity monitoring. The latter was more susceptible
to the confounding effects of opioid administration, in this case
caused by buprenorphine. The considerable individual variation
seen in response to both surgery and analgesic administration
supports a recommendation that dose rates should be adjusted in
relation to the potential severity of the surgical procedure, the
mouse strain, and the individual animals’ response. This is likely to
be achieved by assessing pain and procedure-specific abnormal
behaviour changes. We would also recommend assessing multi-
modal analgesic regimens for post-surgical pain relief in mice, for
example by combining buprenorphine and an NSAID. This could
avoid the confounding effects likely to be associated with use of
higher doses of buprenorphine (i.e. .0.05 mg/kg) but still
improve the degree of pain control.
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